| Recruiting | Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients NCT06751992 | Massachusetts General Hospital | Phase 4 |
| Not Yet Recruiting | Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Ca NCT06881927 | University Hospital, Strasbourg, France | Phase 4 |
| Recruiting | Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients NCT07532694 | Military Hospital 103 | N/A |
| Recruiting | Velocity-Based Resistance Training in Kidney Transplant Recipients NCT07370727 | Fundación Universitaria del Area Andina | N/A |
| Recruiting | Exercise and Diet Effects in Reducing Cardiovascular Risk in Kidney Transplant Recipients NCT06806670 | IRCCS Azienda Ospedaliero-Universitaria di Bologna | N/A |
| Recruiting | The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Recept NCT05938712 | University Health Network, Toronto | Phase 2 |
| Recruiting | Pilot Trial of Supplemental Vitamin A and Nicotinamide NCT05702398 | Rhode Island Hospital | EARLY_Phase 1 |
| Completed | The Effects of Physical Activity Behavior Change in Kidney Transplant Recipients NCT05425498 | Dokuz Eylul University | N/A |
| Unknown | An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant R NCT05293704 | Lee's Pharmaceutical Limited | Phase 4 |
| Completed | COVID Protection After Transplant-Immunosuppression Reduction NCT05077254 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | COVID-19 Protection After Transplant Pilot Study NCT04969263 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Efficacy, Mechanisms and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients NCT04965935 | University Health Network, Toronto | Phase 3 |
| Terminated | Immunological Follow-up After SARS CoV2 Vaccination in Kidney Transplant Recipients NCT04757883 | University Hospital, Strasbourg, France | — |
| Unknown | Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen NCT04444843 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Unknown | Prostate Cancer in Renal Transplants Recipients NCT04642833 | University of Florence | — |
| Completed | Treg Modulation With CD28 and IL-6 Receptor Antagonists NCT04066114 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | Envarsus XR Compared to Immediate Release Tacrolimus NCT03979365 | Mayo Clinic | Phase 4 |
| Unknown | Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation NCT02424227 | CareDx | — |
| Completed | Observational Study to Evaluate the Safety and Efficacy of ATG-F on Kidney Transplant Recipients NCT02392312 | Astellas Pharma China, Inc. | — |
| Completed | Role of Epoxyeicosatrienoic Acids in Chronic Allograft Nephropathy - The TRANSPLANT-EETs Study NCT02555566 | University Hospital, Rouen | N/A |
| Withdrawn | Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring NCT02058875 | University of Saskatchewan | Phase 4 |
| Terminated | A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to NCT02268201 | Astellas Pharma China, Inc. | Phase 4 |
| Completed | Pharmacokinetic Studies of Tacrolimus in Transplant Patients NCT01889758 | University of Cincinnati | Phase 4 |
| Completed | Validation of Gene Expression Markers of Renal Allograft Functional Decline NCT01782586 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Unknown | KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) NCT02042963 | Seoul National University Hospital | — |
| Unknown | A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus NCT01608412 | Hospital de Clinicas de Porto Alegre | Phase 4 |
| Terminated | Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation NCT01517984 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients NCT01150487 | Mayo Clinic | N/A |
| Completed | Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients NCT01336296 | University of Cincinnati | Phase 4 |
| Completed | Measuring and Improving Medication Adherence in Kidney Transplant Patients NCT02639949 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | N/A |
| Completed | Study of the Renal Perfusion in Healthy Volunteers and Renal Transplant Recipients During an Orthostatic Stres NCT02179411 | University Hospital, Angers | N/A |
| Completed | A Multivitamin Comparison Study in Kidney Transplant Recipients. NCT00217100 | Mayo Clinic | Phase 3 |
| Completed | An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in NCT00239044 | Novartis Pharmaceuticals | Phase 3 |
| Unknown | Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant Recipients NCT00199667 | University Hospital, Limoges | Phase 4 |
| Terminated | Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients NCT00005009 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |